MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.
-
Branche
-
Biotechnologieforschung
-
Größe
-
51–200 Beschäftigte
-
Hauptsitz
-
Lausanne
-
Art
-
Privatunternehmen
-
Gegründet
-
2012
-
Spezialgebiete
-
Medical devices, Neurorehabilitation, Virtual reality, Brain imaging, Neurotechnology, 3D Technology, neural prediction, brain computer interface und engineering